The Effect of Cytokines on Osteoblasts and Osteoclasts in Bone Remodeling in Osteoporosis: a Review

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2023 Jul 21

PMID 37475866

Authors

Jie Xu

Linxin Yu

Feng Liu

Longbiao Wan

Zhenhua Deng

Affiliations

Soon will be listed here.

Abstract

The complicated connections and cross talk between the skeletal system and the immune system are attracting more attention, which is developing into the field of Osteoimmunology. In this field, cytokines that are among osteoblasts and osteoclasts play a critical role in bone remodeling, which is a pathological process in the pathogenesis and development of osteoporosis. Those cytokines include the tumor necrosis factor (TNF) family, the interleukin (IL) family, interferon (IFN), chemokines, and so on, most of which influence the bone microenvironment, osteoblasts, and osteoclasts. This review summarizes the effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis, aiming to providing the latest reference to the role of immunology in osteoporosis.

Citing Articles

Serum A20 level is associated with bone mineral density in male patients with type 2 diabetes mellitus.

Han D, Liu J, Wang Y, Wang H, Yuan L, Jin W Front Endocrinol (Lausanne). 2025; 16:1490214.

PMID: 40078583 PMC: 11899168. DOI: 10.3389/fendo.2025.1490214.

Dual functional hydrogel of osteoclastic-inhibition and osteogenic-stimulation for osteoporotic bone defect regeneration.

Yu L, Wang W, Lv C, Chen Q, Yang P, Qi Z Mater Today Bio. 2025; 31:101550.

PMID: 40018058 PMC: 11867540. DOI: 10.1016/j.mtbio.2025.101550.

Effects of ADRM1 on osteoblast differentiation and mineralization in osteoporosis.

Zhuang H, Lin Y, Lin C, Zheng M, Yao X, Xu Y Am J Transl Res. 2025; 17(1):416-428.

PMID: 39959199 PMC: 11826214. DOI: 10.62347/XSOV4523.

Dietary glycemic and insulin indices with the risk of osteoporosis: results from the Iranian teachers cohort study.

HoushiarRad A, Fotros D, Esmaili M, Sohouli M, Ajami M, Abdollahi M Front Nutr. 2025; 11():1415817.

PMID: 39839276 PMC: 11747129. DOI: 10.3389/fnut.2024.1415817.

Anthocyanins from a new hybrid sweet potato peel cultivated in Northern Thailand mitigate LPS-induced inflammation and RANKL-induced osteoporosis by regulating ROS-mediated pathways.

Saenjum C, Thim-Uam A, Khonthun C, Oonlao P, Nuntaboon P, Surh Y Inflammopharmacology. 2025; 33(1):381-399.

PMID: 39806052 PMC: 11799051. DOI: 10.1007/s10787-024-01634-5.

References

Wang Y, Zhang W, Lim S, Xu L, Jin J . Interleukin-10-Producing B Cells Help Suppress Ovariectomy-Mediated Osteoporosis. Immune Netw. 2021; 20(6):e50. PMC: 7779870. DOI: 10.4110/in.2020.20.e50. View

Huang H, Kim H, Chang E, Lee Z, Hwang S, Kim H . IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ. 2009; 16(10):1332-43. DOI: 10.1038/cdd.2009.74. View

Li Q, Kawamura K, Tada Y, Shimada H, Hiroshima K, Tagawa M . Novel type III interferons produce anti-tumor effects through multiple functions. Front Biosci (Landmark Ed). 2013; 18(3):909-18. DOI: 10.2741/4152. View

Chen L, Wei X, Evans B, Jiang W, Aeschlimann D . IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-kappaB (RANK) expression in myeloid precursor cells. Eur J Immunol. 2008; 38(10):2845-54. DOI: 10.1002/eji.200838192. View

Nelms K, Keegan A, Zamorano J, Ryan J, Paul W . The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999; 17:701-38. DOI: 10.1146/annurev.immunol.17.1.701. View

Onoe Y, Miyaura C, Kaminakayashiki T, Nagai Y, Noguchi K, Chen Q . IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. J Immunol. 1996; 156(2):758-64. View

Gupta N, Barhanpurkar A, Tomar G, Srivastava R, Kour S, Pote S . IL-3 inhibits human osteoclastogenesis and bone resorption through downregulation of c-Fms and diverts the cells to dendritic cell lineage. J Immunol. 2010; 185(4):2261-72. DOI: 10.4049/jimmunol.1000015. View

Kohara H, Kitaura H, Fujimura Y, Yoshimatsu M, Morita Y, Eguchi T . IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions. Immunol Lett. 2011; 137(1-2):53-61. DOI: 10.1016/j.imlet.2011.02.017. View

Kitami S, Tanaka H, Kawato T, Tanabe N, Katono-Tani T, Zhang F . IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells. Biochimie. 2010; 92(4):398-404. DOI: 10.1016/j.biochi.2009.12.011. View

10.

Seriolo B, Paolino S, Casabella A, Botticella G, Seriolo C, Molfetta L . Osteoporosis in the elderly. Aging Clin Exp Res. 2013; 25 Suppl 1:S27-9. DOI: 10.1007/s40520-013-0107-9. View

11.

Modur V, Li Y, Zimmerman G, Prescott S, McIntyre T . Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J Clin Invest. 1998; 100(11):2752-6. PMC: 508479. DOI: 10.1172/JCI119821. View

12.

Xu L, Kukita T, Kukita A, Otsuka T, Niho Y, Iijima T . Interleukin-10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast-like cells in rat bone marrow culture system. J Cell Physiol. 1995; 165(3):624-9. DOI: 10.1002/jcp.1041650321. View

13.

Okabe I, Kikuchi T, Mogi M, Takeda H, Aino M, Kamiya Y . IL-15 and RANKL Play a Synergistically Important Role in Osteoclastogenesis. J Cell Biochem. 2016; 118(4):739-747. DOI: 10.1002/jcb.25726. View

14.

Hiasa M, Abe M, Nakano A, Oda A, Amou H, Kido S . GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-alpha converting enzyme (TACE). Blood. 2009; 114(20):4517-26. DOI: 10.1182/blood-2009-04-215020. View

15.

Barhanpurkar A, Gupta N, Srivastava R, Tomar G, Naik S, Joshi S . IL-3 promotes osteoblast differentiation and bone formation in human mesenchymal stem cells. Biochem Biophys Res Commun. 2012; 418(4):669-75. DOI: 10.1016/j.bbrc.2012.01.074. View

16.

Van Vlasselaer P, Borremans B, van den Heuvel R, Gorp U, de Waal Malefyt R . Interleukin-10 inhibits the osteogenic activity of mouse bone marrow. Blood. 1993; 82(8):2361-70. View

17.

Salopek D, Grcevic D, Katavic V, Kovacic N, Lukic I, Marusic A . Increased bone resorption and osteopenia are a part of the lymphoproliferative phenotype of mice with systemic over-expression of interleukin-7 gene driven by MHC class II promoter. Immunol Lett. 2008; 121(2):134-9. DOI: 10.1016/j.imlet.2008.10.002. View

18.

Girasole G, Jilka R, Passeri G, Boswell S, Boder G, Williams D . 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest. 1992; 89(3):883-91. PMC: 442934. DOI: 10.1172/JCI115668. View

19.

Fernandes T, Hodge J, Singh P, Eeles D, Collier F, Holten I . Cord blood-derived macrophage-lineage cells rapidly stimulate osteoblastic maturation in mesenchymal stem cells in a glycoprotein-130 dependent manner. PLoS One. 2013; 8(9):e73266. PMC: 3772005. DOI: 10.1371/journal.pone.0073266. View

20.

Son H, Lee J, Lee H, Kim N, Jo Y, Lee G . Benzydamine inhibits osteoclast differentiation and bone resorption down-regulation of interleukin-1 expression. Acta Pharm Sin B. 2020; 10(3):462-474. PMC: 7049613. DOI: 10.1016/j.apsb.2019.11.004. View